WO1996025913A1 - Preparation - Google Patents

Preparation Download PDF

Info

Publication number
WO1996025913A1
WO1996025913A1 PCT/EP1996/000679 EP9600679W WO9625913A1 WO 1996025913 A1 WO1996025913 A1 WO 1996025913A1 EP 9600679 W EP9600679 W EP 9600679W WO 9625913 A1 WO9625913 A1 WO 9625913A1
Authority
WO
WIPO (PCT)
Prior art keywords
zinc
hydroxycarbonate
water
monophasic
personal care
Prior art date
Application number
PCT/EP1996/000679
Other languages
French (fr)
Inventor
Ramachandra Bhat
Nand Sanmukhdas Bijlani
Venkateswaran Krishnan
Devadatta Shivaji Sankholkar
Original Assignee
Unilever N.V.
Unilever Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever N.V., Unilever Plc filed Critical Unilever N.V.
Priority to AU48778/96A priority Critical patent/AU4877896A/en
Publication of WO1996025913A1 publication Critical patent/WO1996025913A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G9/00Compounds of zinc
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants

Definitions

  • This invention relates to preparation of zinc hydroxycarbonate and antimicrobial compositions containing that compound.
  • This invention particularly relates to:
  • compositions such as toothpastes, toothpowders, toilet soaps, skin creams, skin powders, deodorants, antiperspirants and hair care products comprising zinc hydroxycarbonate as an antimicrobial agent.
  • Zinc hydroxycarbonate occurs in nature in the mineral hydrozincite. Generally sulphide ore bodies are overlain by deposits of smithsonite, calamine and hydrozincite. Franklinite, willemite and zincite occur in white crystalline lime stone in some places. Calcite, dolomite and sometimes quartz occurs as materials associated with zinc blend or sulphide.
  • the monophasic zinc hydroxycarbonate prepared by the process of present invention has a structure similar to that of hydrozincite without any other impurity phases as may be present in the mineral.
  • Basic zinc carbonate may be represented by
  • Zn 4 (C0 3 ) . (0H) 6 . or Zn 5 (C0 S ) 2 . (OH) unfortunately and sometimes it is accompanied with ZnO.
  • the monophasic zinc hydroxycarbonate of the present invention has the following formula
  • divalent zinc ions can provide antimicrobial activity. If they are made available freely in soaps or cosmetic or dental formulations, they would contribute to the health care features of these products. But the zinc ions tend to affect colour, perfume, flavour, and/or taste of the cosmetic products, dental products or soaps, and they may reduce the shelf life of such products. Due to the structure of the hydrozincite (in which zinc is present in the form of stable covalent complexes) , free divalent zinc ions are not made available in the product. Thereby the shelf life of the health care products is improved.
  • Zinc hydroxycarbonate is also an antimicrobial compound, and it is surprisingly found that when a personal care product containing it comes into contact with the skin or with the saliva in the mouth, or the microflora of the skin, scalp or hair, the zinc hydroxycarbonate in the presence of a surfactant such as soap and/or synthetic detergent shows a synergistic enhancement of the antimicrobial effect. Further its substantivity keeps it on the body to readily deliver free divalent zinc ions to act as antimicrobial agent at the site as and when desired.
  • a surfactant such as soap and/or synthetic detergent
  • the zinc hydroxycarbonate not being soluble in water, is substantive to the skin, mucous membranes, hair, mould and microbial cell walls particularly wherever there is any acid site, and upon neutralising the acid site delivers divalent zinc ions which act on microbes which generate acids such as butyric and lactic acids.
  • the surfactant e.g. soap and/or synthetic detergents place the zinc hydroxycarbonate onto the desired spot.
  • the combination not only gives synergistic effect in antimicrobial activity in use but also gives triggered release effect during the intervening period inbetween successive application of the products containing it.
  • zinc hydroxycarbonate acts as an agent to generate active antibacterial/antimicrobial species - divalent zinc ions - by its synergistic combination with surfactants such as soaps/synthetic detergents.
  • This reference describes a process for the preparation of catalysts for synthesis of methanol from carbon oxides wherein a mixture of hydroxycarbonates of copper/zinc/aluminium/rare earth metal and/or zirconium is prepared by a co-precipitation technique.
  • soluble salts are dissolved together and reacted with ammonium, sodium, potassium carbonates, and/or hydroxides n the pH range 6.3-7.3.
  • This reference describes the preparation of an antimicrobial drug comprising supplying continuously aluminium, an aqueous solution of antimicrobial metal salts (including copper, zinc, magnesium, nickel and cobalt) , sodium carbonate solution and sodium hydroxide solution into a reaction tank at room temperature keeping the pH of the reaction solution at 7 to 11 by adjusting the NaOH addition, filtering the reacted suspension, rinsing with water and drying.
  • the molar ratio of aluminium and copper ion salt is 1:1 to 4:1.
  • the present invention relates to
  • antimicrobial personal care products such as toothpastes, toothpowders, soaps, skin cream, skin powders, deodorants, antiperspirants and hair care products comprising zinc hydroxycarbonate, and a surfactant such as soap or a synthetic detergent.
  • the process of the present invention for the preparation of zinc hydroxycarbonate (suitable for use as antimicrobial agent in personal care compositions such as soaps, cosmetic - skin and hair- and dental formulations) comprises
  • the soluble zinc salt may be chloride, sulphate or nitrate.
  • the pH of the reaction is between 8-10; preferably about 9.
  • the preferred temperature of the precipitation reaction is 50-98 °C; more preferred is 80-90 °C.
  • the product of the reaction is air dried at temperature upto 150 °C. Vacuum drying may be used.
  • the precipitated basic zinc carbonate obtained by the process of the invention was identified by XRD, IR, SEM Morphology and its Zn content was found to be between 54.75 to 59.55 %.
  • the chemical formula was found to be
  • X varies between 0 and 4 depending on the drying temperature and duration of drying.
  • the antimicrobial personal care compositions of the invention comprise from 0.1 % to 20 % by weight of monophasic zinc hydroxycarbonate in combination with the usual ingredients of personal care compositions comprising a soap or detergent, with or without other antimicrobial agents.
  • the material obtained is not suitable for cosmetic use. It is more gritty than required.
  • sodium carbonate solution and the zinc salt solution are simultaneously pumped in the precipitation vessel, the physical properties of the material obtained are very close to the requirement of the formulations.
  • Zinc hydroxycarbonate shows synergistic antimicrobial activity in toothpastes with any abrasive agents such as chalk, silica, dicalciumphosphate dihydrate (DCPD) , alumina trihydrate.
  • any abrasive agents such as chalk, silica, dicalciumphosphate dihydrate (DCPD) , alumina trihydrate.
  • the zinc hydroxycarbonate neutralises organic acids such as lactic acid as and when they are generated in the mouth, and the release of zinc ions is triggered off as a result of this neutralisation of zinc with e.g. lactic acid acting on oral microflora. This process is likely to help to reduce plaque pH and buffer the plaque.
  • This is another facet of the invention.
  • Synergistic action of zinc hydroxycarbonate with detergent and/or antidandruff actives like zinc pyrithione in shampoos/hair dressings is yet another aspect of this invention.
  • Synergistic action of zinc hydroxycarbonate in skin cream and talcum powder is yet another example of this invention. It has the added advantage of reducing body malodour caused by some of the fatty acids, hydroxy acids and their breakdown products, present in body malodour.
  • Zinc sulphate heptahydrate 300 g was dissolved in water (1000 ml) .
  • Sodium carbonate 150 g was dissolved in water (1000 ml) .
  • Soaps containing monophasic zinc hydroxycarbonate (ZHC) with and without trichlorocarbanilide (TCC) were evaluated for their antibacterial activity by the Bureau of Indian Standards' Test method given in IS 11479 - 1985.
  • Soap base used in these compositions had 55 % TFM (12.5 % CNO) ; 24 % Structurant (talc) ; 1.5 % Tetrasodium pyrophosphate, 0.5 % sodium carbonate.
  • Example 3 Evaluation of toothpastes containing zinc hydroxycarbonates
  • the antimicrobial activity of the toothpaste was assessed by [the in-vitro method described below] estimating total viable count by spread plate technique as described in Medical Microbiology by R. Cruickshank, 11th Edn., 1965, pp 886-889.
  • Toothpaste base* (0.1 % on the broth) 23.6
  • Toothpaste base + 2 % ZHC
  • SCMC Sodium carboxymethylcellulose
  • Titanium dioxide 1.0 Sodium lauryl sulphate 2.5 2.5
  • Sorbitol (70 %) and water were taken into a vacuum mixer fitted with a low speed scraper unit and a high speed homogeniser. Minor soluble compounds such as saccharin, monosodium phosphate etc. were added to obtain clear solution.
  • the mixture was heated to 50 °C and mixture of SCMC and abrasive chalk/silica was added. The mixture was homogenised and thickening silica was subsequently added.
  • detergents consisting of sodium lauryl sulphate and dodecyl benzene sulphonate predissolved in water were added.
  • the batch was cooled to 40 °C. Zinc hydroxycarbonate was then added and mixing was continued. Flavour was added last to complete the batch.
  • n-butyric acid 0.5 % solution
  • zinc hydroxycarbonate 5g in 30 ml slurry
  • the filtrate was analysed for soluble Zn++ ions and its pH was recorded.

Abstract

The invention relates to the use of monophasic zinc hydroxycarbonate as antimicrobial agent in personal care products, particularly in such products which also contain a surfactant such as a soap or a synthetic detergent. The invention also relates to a process for making the zinc hydroxycarbonate, whereby a solution of a soluble zinc salt and a solution of alkalimetal carbonate are fed simultaneously into a precipitation vessel to form a precipitate of monophasic zinc hydroxycarbonate.

Description

--
1
PREPARATION INTRODUCTION
This invention relates to preparation of zinc hydroxycarbonate and antimicrobial compositions containing that compound.
This invention particularly relates to:
a) preparation of monophasic zinc hydroxycarbonate suitable for use in personal care products such as toilet soaps and cosmetics like skin, scalp and/or hair products and dental products such as toothpastes, toothpowders, dental creams and
b) personal care compositions such as toothpastes, toothpowders, toilet soaps, skin creams, skin powders, deodorants, antiperspirants and hair care products comprising zinc hydroxycarbonate as an antimicrobial agent.
BACKGROUND
Zinc hydroxycarbonate occurs in nature in the mineral hydrozincite. Generally sulphide ore bodies are overlain by deposits of smithsonite, calamine and hydrozincite. Franklinite, willemite and zincite occur in white crystalline lime stone in some places. Calcite, dolomite and sometimes quartz occurs as materials associated with zinc blend or sulphide. The monophasic zinc hydroxycarbonate prepared by the process of present invention has a structure similar to that of hydrozincite without any other impurity phases as may be present in the mineral.
Basic zinc carbonate may be represented by
Zn4(C03) . (0H)6. or Zn5 (C0S) 2. (OH) „ and sometimes it is accompanied with ZnO.
The monophasic zinc hydroxycarbonate of the present invention has the following formula
Zn5(C03)2. (OH)j.x H20 (x = 0-4)
It is known that divalent zinc ions can provide antimicrobial activity. If they are made available freely in soaps or cosmetic or dental formulations, they would contribute to the health care features of these products. But the zinc ions tend to affect colour, perfume, flavour, and/or taste of the cosmetic products, dental products or soaps, and they may reduce the shelf life of such products. Due to the structure of the hydrozincite (in which zinc is present in the form of stable covalent complexes) , free divalent zinc ions are not made available in the product. Thereby the shelf life of the health care products is improved. Zinc hydroxycarbonate is also an antimicrobial compound, and it is surprisingly found that when a personal care product containing it comes into contact with the skin or with the saliva in the mouth, or the microflora of the skin, scalp or hair, the zinc hydroxycarbonate in the presence of a surfactant such as soap and/or synthetic detergent shows a synergistic enhancement of the antimicrobial effect. Further its substantivity keeps it on the body to readily deliver free divalent zinc ions to act as antimicrobial agent at the site as and when desired. It is hypothesised here that the zinc hydroxycarbonate, not being soluble in water, is substantive to the skin, mucous membranes, hair, mould and microbial cell walls particularly wherever there is any acid site, and upon neutralising the acid site delivers divalent zinc ions which act on microbes which generate acids such as butyric and lactic acids. The surfactant, e.g. soap and/or synthetic detergents place the zinc hydroxycarbonate onto the desired spot. Thus, it is thought that the combination not only gives synergistic effect in antimicrobial activity in use but also gives triggered release effect during the intervening period inbetween successive application of the products containing it. Thus, zinc hydroxycarbonate acts as an agent to generate active antibacterial/antimicrobial species - divalent zinc ions - by its synergistic combination with surfactants such as soaps/synthetic detergents.
PRIOR ART
There are processes known for the preparation of basic zinc carbonate. Preparation of monophasic zinc hydroxycarbonate suitable for use in personal products has not been described. Use of mineral hydrozincite in dental preparations has been reported, but synergistic antimicrobial compositions containing zinc hydroxycarbonates have not been reported in the literature.
In a Russian process degradation of zinc ammonium carbonate complexes with hot moist air in the presence of lignin sulphonate gives zinc hydroxycarbonate. [Krechmer G.A. ; SU
664923 (30 May 1979) ] .
In another Russian process, basic zinc carbonate is prepared by an electro-chemical process from an electrolyte containing sodium nitrate and sodium bicarbonate. [Oratovskii V.I.; SU 447366 (22 August 1975)].
In another process, zinc hydroxide ( a waste product from the production of Na2S204 was used as raw material for the production of basic zinc carbonate (ZnC03.3Zn(OH)2) by carbonation. [Telepneva A.E. and Artemova V.A. , Tr. Ural. Nauch. -Issled. Khim. Inst. 1973, 24.. 26-8] . Further prior art references are:
a. Inst. Francais D Petrole: EP 015586R (20 February 1985)
This reference describes a process for the preparation of catalysts for synthesis of methanol from carbon oxides wherein a mixture of hydroxycarbonates of copper/zinc/aluminium/rare earth metal and/or zirconium is prepared by a co-precipitation technique. In this process soluble salts are dissolved together and reacted with ammonium, sodium, potassium carbonates, and/or hydroxides n the pH range 6.3-7.3.
b. Fu-ii Chem. Ind. Co. : JP 5025052 (2 February 1993)
This reference describes the preparation of an antimicrobial drug comprising supplying continuously aluminium, an aqueous solution of antimicrobial metal salts (including copper, zinc, magnesium, nickel and cobalt) , sodium carbonate solution and sodium hydroxide solution into a reaction tank at room temperature keeping the pH of the reaction solution at 7 to 11 by adjusting the NaOH addition, filtering the reacted suspension, rinsing with water and drying. The molar ratio of aluminium and copper ion salt is 1:1 to 4:1.
c. Vian A. fit, al.. An Ouim. Ser. A.. 1984. 80(3) Suppl. 2 . 724-31 (Spanish) fCA: 103: 89773v1
According to this reference, in connection with recovery of zinc from ion-exchange wash liquors, used in the leaching of pyrite cinders, NaOH, Ca(0H)2, and A(OH)-Na2C03 mixture, (where A = Na, K, NH4) were used to precipitate zinc from zinc chloride solution. While NaOH produced a precipitate consisting of [ZnO and Zn5(OH)β.Cl2.H20] , A(0H) and Na2C03 mixtures gave a precipitate consisting mainly of [ZnO and Zn5 (C03)2 (OH)β] with various proportions.
In French patent 2493704, the use of natural carbonates forming an isomorphic series with the calcite, more resistant to acids than Iceland Spar (this includes natural hydrozincite) has been reported for treatment or prevention of the troubles from demineralisation of hard tissues such as teeth.
DEFINITION OF THE INVENTION
Accordingly, the present invention relates to
a) a process for the preparation of monophasic zinc hydroxycarbonate suitable for use in personal care products and
b) antimicrobial personal care products such as toothpastes, toothpowders, soaps, skin cream, skin powders, deodorants, antiperspirants and hair care products comprising zinc hydroxycarbonate, and a surfactant such as soap or a synthetic detergent.
The process of the present invention for the preparation of zinc hydroxycarbonate, (suitable for use as antimicrobial agent in personal care compositions such as soaps, cosmetic - skin and hair- and dental formulations) comprises
(i) dissolving a soluble zinc sal ^in water and heating it, to keep the solution warm before use,
(ii) dissolving an alkali metal carbonate, such as sodium potassium or ammonium carbonate, in water,
(iii) taking water in a precipitation vessel and maintaining it at 35-95 °C, (iv) pumping warm solutions of (i) and (ii) into the precipitation vessel simultaneously, and maintaining the temperature at 50-98 °C with continuous stirring and warming if necessary,
(v) filtering off the precipitate and washing it with water until it is free from anions, and
(vi) drying the washed material.
The soluble zinc salt may be chloride, sulphate or nitrate. The pH of the reaction is between 8-10; preferably about 9.
The preferred temperature of the precipitation reaction is 50-98 °C; more preferred is 80-90 °C.
The product of the reaction is air dried at temperature upto 150 °C. Vacuum drying may be used.
The precipitated basic zinc carbonate obtained by the process of the invention was identified by XRD, IR, SEM Morphology and its Zn content was found to be between 54.75 to 59.55 %. The chemical formula was found to be
Zn5(OH)β(C03)2.X.H20
X varies between 0 and 4 depending on the drying temperature and duration of drying.
The antimicrobial personal care compositions of the invention comprise from 0.1 % to 20 % by weight of monophasic zinc hydroxycarbonate in combination with the usual ingredients of personal care compositions comprising a soap or detergent, with or without other antimicrobial agents. DETAILS OF THE INVENTION
If the sodium carbonate solution is taken in the precipitation vessel initially, and zinc salt solution is thereafter pumped into it or vice versa, the material obtained is not suitable for cosmetic use. It is more gritty than required. On the other hand when sodium carbonate solution and the zinc salt solution are simultaneously pumped in the precipitation vessel, the physical properties of the material obtained are very close to the requirement of the formulations.
When the zinc hydroxycarbonate is prepared as above by precipitation at different temperatures viz., 50, 70 and 85 °C it has been found that all these products exhibit a hydrozincite structure. However, when it is precipitated at room temperature, the product is not monophasic.
Synergistic action of zinc hydroxycarbonate with soaps containing TCC (trichlorocarbanilide) is another facet of this invention.
Synergistic action of zinc hydroxycarbonate with toothpastes containing soaps and/or detergents such as sodium ricinoleate, sodium lauryl sulphate, is yet another facet of this invention. Zinc hydroxycarbonate shows synergistic antimicrobial activity in toothpastes with any abrasive agents such as chalk, silica, dicalciumphosphate dihydrate (DCPD) , alumina trihydrate.
The zinc hydroxycarbonate neutralises organic acids such as lactic acid as and when they are generated in the mouth, and the release of zinc ions is triggered off as a result of this neutralisation of zinc with e.g. lactic acid acting on oral microflora. This process is likely to help to reduce plaque pH and buffer the plaque. This is another facet of the invention. Synergistic action of zinc hydroxycarbonate with detergent and/or antidandruff actives like zinc pyrithione in shampoos/hair dressings is yet another aspect of this invention.
Synergistic action of zinc hydroxycarbonate in skin cream and talcum powder is yet another example of this invention. It has the added advantage of reducing body malodour caused by some of the fatty acids, hydroxy acids and their breakdown products, present in body malodour.
The neutralisation of organic acids such as butyric acid generated on skin which is responsible for malodour by the zinc hydroxycarbonate release zinc ions acting on the skin microflora. It also acts as a buffer to control the pH in the area of its action on skin. The synergistic compositions such as deodorants, antiperspirants are based on this principle and it is another facet of the invention.
EXAMPLES
The invention will now be illustrated by way of Examples. The Examples are for illustration only and they do not in any way restrict the scope of the invention.
Example 1: Preparation of monophasic zinc hydroxycarbonate
Materials used in this Example were of technical grade.
1. Zinc sulphate heptahydrate (300 g) was dissolved in water (1000 ml) . Sodium carbonate (150 g) was dissolved in water (1000 ml) .
2. In the precipitation vessel (5000 ml) 200 ml water was taken and maintained at 85 °C.
3. Warm solutions of zinc sulphate and sodium carbonate were pumped into the precipitation vessel simultaneously maintaining the precipitation temperature at 85 °C, with continuous stirring.
4. When all the solutions were added and the precipitation completed, the precipitate was filtered through a Buchner funnel, and washed with hot (60 °C) water (2000 ml) .
5. The product was dried in an air oven at 110 °C for six hours. Yield: 125 g (100 %) .
Analysis of the product :
Zn content:
55 % by wt. (EDTA Titration using Eriochrome Black T)
Surface Area: 80 m2/g (BET method)
X-Ray (powder) diffraction pattern: it indicated a highly crystalline nature of the product and it was isostructural with the mineral hydrozincite.
FT-IR Spectra: it indicated a basic carbonate group. [- absorption doublets at 1507 and 1385 cm _1. This was confirmed by adsorption maxima at 1046 (bridging type OH: bending mode) ; at 835 (out-of-plane C03 deformation) ; at 708 (in-plane C03 deformation) and at 470 cm"1 (ZnO symmetric stretching)] .
Example 2: Evaluation of soaps containing zinc hydroxycarbonate
Soaps containing monophasic zinc hydroxycarbonate (ZHC) with and without trichlorocarbanilide (TCC) were evaluated for their antibacterial activity by the Bureau of Indian Standards' Test method given in IS 11479 - 1985.
Results are given in Table 1.
Table 1
Composi ion Subs ant-ivity
1. Soap base* No
2. Soap base + 0.1 % TCC No 3. Soap base + 0.5 % ZHC No
4. Soap base + 0.1 % TCC + 0.5 % ZHC Yes
* Soap base used in these compositions had 55 % TFM (12.5 % CNO) ; 24 % Structurant (talc) ; 1.5 % Tetrasodium pyrophosphate, 0.5 % sodium carbonate.
These results clearly showed that very small amounts of TCC when mixed with small amounts of ZHC synergistically reduced the microbial activity and improved substantivity much more than either of them individually with soap base.
Example 3: Evaluation of toothpastes containing zinc hydroxycarbonates
The antimicrobial activity of the toothpaste was assessed by [the in-vitro method described below] estimating total viable count by spread plate technique as described in Medical Microbiology by R. Cruickshank, 11th Edn., 1965, pp 886-889.
The results of the assay are given in Table 2.
Table 2 Antimicrobial activity of toothpastes containing zinc hydroxycarbonate CP pQSi ΪQΠ % Inhibition
1. Toothpaste base*: (0.1 % on the broth) 23.6
2. Toothpaste base + 2 % ZHC:
(0.1 % - 20 ppm ZHC - on the broth) 86.2
3. 20 ppm ZHC (as slurry) on the broth 41.3
* Composition of the toothpaste base is same as that given in Example 4A without any addition of ZHC.
The results clearly indicated that the Composition 2 had a synergistic inhibitory activity.
In-vitro method:
Appropriate dilutions of toothpaste are incubated with a Streptococcus spp. culture isolated from the oral microflora. An aliquot of this is taken and placed on an Agar plate for growth at room temperature overnight. The following day colony forming units (CFU) are counted. The activity is expressed as % inhibition. This is calculated based on the growth of bacteria (no of CFUs) without any treatment, which is taken as 100 % growth or 0 % inhibition.
Example 4: Toothpaste compositions according to the invention
The following toothpaste compositions were formulated as described below: Composition 4A(%) 4B(%)
Precipitated calcium carbonate (Chalk) 40.0
Abrasive silica 10.0 Thickening silica 1.5 8.3
Sorbitol (70 %) 27.0 45.0
Sodium carboxymethylcellulose (SCMC) 0.7 0.9
Sodium saccharin 0.2 0.2
Titanium dioxide 1.0 Sodium lauryl sulphate 2.5 2.5
Sodium dodecylbenzenesulphonate (40 %) 1.0 0.5
Monosodium phosphate 0.4
Zinc hdyroxycarbonate 2.0 2.0
Flavour q.s. q.s.
Demineralised water to 100 100
Method of preparation
Sorbitol (70 %) and water were taken into a vacuum mixer fitted with a low speed scraper unit and a high speed homogeniser. Minor soluble compounds such as saccharin, monosodium phosphate etc. were added to obtain clear solution. The mixture was heated to 50 °C and mixture of SCMC and abrasive chalk/silica was added. The mixture was homogenised and thickening silica was subsequently added. When the mixture was of consistent quality, detergents consisting of sodium lauryl sulphate and dodecyl benzene sulphonate predissolved in water were added. The batch was cooled to 40 °C. Zinc hydroxycarbonate was then added and mixing was continued. Flavour was added last to complete the batch.
Example 5: Nent-ralisation of zinc hydroxycarbona e with n- butyric acid
Various quantities of n-butyric acid (0.5 % solution) were added to zinc hydroxycarbonate (5g in 30 ml slurry) and the filtrate was analysed for soluble Zn++ ions and its pH was recorded.
Results are given in table 3.
Table 3
Mole ratio of Soluble Zn++ ions pH of the butyric acid: ZHC in the filtrate filtrate (% zinc on ZHC weight)
0 Nil 6.6
4 42.58 6.0
6 61.92 5.9 10 81.02 5.8
12 100.0 5.5
This Example supported our hypothesis of triggered release action of ZHC and buffering of the pH of the solution.

Claims

Claims
1. An antimicrobial personal care product comprising a surfactant and an antimicrobial agent, characterised in that the antimicrobial agent is or comprises monophasic zinc hydroxycarbonate.
2. A product according to claim 1, characterised in that the monophasic zinc hydroxycarbonate is present in an amount of 0.1 - 20 % by weight of the product.
3. A product according to claim 1 or 2, characterised in that the surfactant is a soap or a synthetic detergent.
4. A product according to claims 1-3, characterised in that the personal care product is a toilet soap.
5. A product according to claims 1-3, characterised in that the personal care product is a toothpaste.
6. A process for the preparation of monophasic zinc hydroxycarbonate, suitable for use in the products according to claims 1-5, said process comprising the steps of (i) dissolving a soluble zinc salt in water and heating he resulting solution, (ii) dissolving an alkalimetal carbonate in water, (iii) placing water in a precipitation vessel and maintaining the water at a temperature of
- w between 35-95 °C,
(iv) placing the solutions i) and ii) simultaneously into the precipitation vessel with warm water according to iii) , and maintaining the temperature at 50-98 °C with continuous stirring,
(v) filtering-off the precipitate formed during step iv) and washing the filtrate with water until it is free from anions, and (vi) drying the washed material.
7. Use of monophasic zinc hydroxycarbonate as antimicrobial agent in personal care product.
PCT/EP1996/000679 1995-02-20 1996-02-14 Preparation WO1996025913A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU48778/96A AU4877896A (en) 1995-02-20 1996-02-14 Preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9503240.5A GB9503240D0 (en) 1995-02-20 1995-02-20 Preparation
GB9503240.5 1995-02-20

Publications (1)

Publication Number Publication Date
WO1996025913A1 true WO1996025913A1 (en) 1996-08-29

Family

ID=10769861

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1996/000679 WO1996025913A1 (en) 1995-02-20 1996-02-14 Preparation

Country Status (4)

Country Link
AU (1) AU4877896A (en)
GB (1) GB9503240D0 (en)
MA (1) MA23812A1 (en)
WO (1) WO1996025913A1 (en)

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037859A1 (en) * 1997-02-28 1998-09-03 Fertin A/S An oral composition suitable for use in oral hygiene and dental care
US5968539A (en) * 1997-06-04 1999-10-19 Procter & Gamble Company Mild, rinse-off antimicrobial liquid cleansing compositions which provide residual benefit versus gram negative bacteria
US6183763B1 (en) 1997-06-04 2001-02-06 Procter & Gamble Company Antimicrobial wipes which provide improved immediate germ reduction
US6183757B1 (en) 1997-06-04 2001-02-06 Procter & Gamble Company Mild, rinse-off antimicrobial cleansing compositions which provide improved immediate germ reduction during washing
EP1074247A2 (en) * 1999-07-20 2001-02-07 Zschimmer & Schwarz Italiana S.p.A. Cleansing or cosmetic compositions comprising zinc alkylsulphates and/or alky(poly)ethoxysulphates as surfactants and preservatives
US6190675B1 (en) 1997-06-04 2001-02-20 Procter & Gamble Company Mild, rinse-off antimicrobial liquid cleansing compositions which provide improved residual benefit versus gram positive bacteria
US6190674B1 (en) 1997-06-04 2001-02-20 Procter & Gamble Company Liquid antimicrobial cleansing compositions
US6197315B1 (en) 1997-06-04 2001-03-06 Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria
US6210695B1 (en) 1997-06-04 2001-04-03 The Procter & Gamble Company Leave-on antimicrobial compositions
US6214363B1 (en) 1997-11-12 2001-04-10 The Procter & Gamble Company Liquid antimicrobial cleansing compositions which provide residual benefit versus gram negative bacteria
US6284259B1 (en) 1997-11-12 2001-09-04 The Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus Gram positive bacteria
US6287583B1 (en) 1997-11-12 2001-09-11 The Procter & Gamble Company Low-pH, acid-containing personal care compositions which exhibit reduced sting
US6287577B1 (en) 1997-11-12 2001-09-11 The Procter & Gamble Company Leave-on antimicrobial compositions which provide improved residual benefit versus gram positive bacteria
WO2003088957A1 (en) * 2002-04-22 2003-10-30 The Procter & Gamble Company Personal care compositions comprising a zinc containing material in an aqueous surfactant composition
JP2004269372A (en) * 2003-03-05 2004-09-30 Toshiko Hori Composition for coating and applying to human body
WO2004082647A1 (en) * 2003-03-18 2004-09-30 The Procter & Gamble Company Composition comprising zinc-containing layered material with a high relative zinc lability
WO2004082648A1 (en) * 2003-03-18 2004-09-30 The Procter & Gamble Company Composition comprising particulate zinc materials having a defined crystallite size
US7026308B1 (en) 1999-06-25 2006-04-11 The Procter & Gamble Company Topical anti-microbial compositions
ITMI20101153A1 (en) * 2010-06-25 2011-12-26 Farmaceutici Dott Ciccarelli S P A USE OF ANTIBACTERIAL COMPOUNDS FOR ORAL CABLE HYGIENE
WO2013140136A1 (en) * 2012-03-19 2013-09-26 Isis Innovation Ltd Adjuvants
US8778311B2 (en) 2006-03-22 2014-07-15 The Procter & Gamble Company Oral zinc compositions
US8796252B2 (en) 1999-06-25 2014-08-05 Arch Chemicals, Inc. Pyrithione biocides enhanced by zinc metal ions and organic amines
WO2014134731A1 (en) * 2013-03-07 2014-09-12 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof
CN107847522A (en) * 2015-06-12 2018-03-27 杰富意矿物股份有限公司 Skin trauma or pachylosis therapeutic agent
WO2018105739A1 (en) * 2016-12-09 2018-06-14 Jfeミネラル株式会社 Inorganic composition with excellent property of gradually releasing zinc ion, and production method therefor
WO2019011553A1 (en) * 2017-07-11 2019-01-17 Beiersdorf Ag Use of electrolytes in cosmetic preparations for selectively reducing a microorganism population on human skin
US10945935B2 (en) 2016-06-27 2021-03-16 The Procter And Gamble Company Shampoo composition containing a gel network
US11497691B2 (en) 2018-12-14 2022-11-15 The Procter & Gamble Company Shampoo composition comprising sheet-like microcapsules
US11628126B2 (en) 2018-06-05 2023-04-18 The Procter & Gamble Company Clear cleansing composition
US11633072B2 (en) 2021-02-12 2023-04-25 The Procter & Gamble Company Multi-phase shampoo composition with an aesthetic design
US11896689B2 (en) 2019-06-28 2024-02-13 The Procter & Gamble Company Method of making a clear personal care comprising microcapsules
US11932448B2 (en) 2020-02-14 2024-03-19 The Procter & Gamble Company Bottle adapted for storing a liquid composition with an aesthetic design suspended therein

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2493704A1 (en) * 1980-11-07 1982-05-14 Lemouel Jean Compsns. for dental caries and bone demineralisation - contg. an acid:resistant natural carbonate

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2493704A1 (en) * 1980-11-07 1982-05-14 Lemouel Jean Compsns. for dental caries and bone demineralisation - contg. an acid:resistant natural carbonate

Cited By (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037859A1 (en) * 1997-02-28 1998-09-03 Fertin A/S An oral composition suitable for use in oral hygiene and dental care
US5968539A (en) * 1997-06-04 1999-10-19 Procter & Gamble Company Mild, rinse-off antimicrobial liquid cleansing compositions which provide residual benefit versus gram negative bacteria
US6183763B1 (en) 1997-06-04 2001-02-06 Procter & Gamble Company Antimicrobial wipes which provide improved immediate germ reduction
US6183757B1 (en) 1997-06-04 2001-02-06 Procter & Gamble Company Mild, rinse-off antimicrobial cleansing compositions which provide improved immediate germ reduction during washing
US6190675B1 (en) 1997-06-04 2001-02-20 Procter & Gamble Company Mild, rinse-off antimicrobial liquid cleansing compositions which provide improved residual benefit versus gram positive bacteria
US6190674B1 (en) 1997-06-04 2001-02-20 Procter & Gamble Company Liquid antimicrobial cleansing compositions
US6197315B1 (en) 1997-06-04 2001-03-06 Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria
US6210695B1 (en) 1997-06-04 2001-04-03 The Procter & Gamble Company Leave-on antimicrobial compositions
US6287577B1 (en) 1997-11-12 2001-09-11 The Procter & Gamble Company Leave-on antimicrobial compositions which provide improved residual benefit versus gram positive bacteria
US6214363B1 (en) 1997-11-12 2001-04-10 The Procter & Gamble Company Liquid antimicrobial cleansing compositions which provide residual benefit versus gram negative bacteria
US6284259B1 (en) 1997-11-12 2001-09-04 The Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus Gram positive bacteria
US6287583B1 (en) 1997-11-12 2001-09-11 The Procter & Gamble Company Low-pH, acid-containing personal care compositions which exhibit reduced sting
US7026308B1 (en) 1999-06-25 2006-04-11 The Procter & Gamble Company Topical anti-microbial compositions
US8796252B2 (en) 1999-06-25 2014-08-05 Arch Chemicals, Inc. Pyrithione biocides enhanced by zinc metal ions and organic amines
EP1074247A3 (en) * 1999-07-20 2003-01-22 Zschimmer & Schwarz Italiana S.p.A. Cleansing or cosmetic compositions comprising zinc alkylsulphates and/or alky(poly)ethoxysulphates as surfactants and preservatives
EP1074247A2 (en) * 1999-07-20 2001-02-07 Zschimmer & Schwarz Italiana S.p.A. Cleansing or cosmetic compositions comprising zinc alkylsulphates and/or alky(poly)ethoxysulphates as surfactants and preservatives
WO2003088957A1 (en) * 2002-04-22 2003-10-30 The Procter & Gamble Company Personal care compositions comprising a zinc containing material in an aqueous surfactant composition
JP2004269372A (en) * 2003-03-05 2004-09-30 Toshiko Hori Composition for coating and applying to human body
WO2004082647A1 (en) * 2003-03-18 2004-09-30 The Procter & Gamble Company Composition comprising zinc-containing layered material with a high relative zinc lability
WO2004082648A1 (en) * 2003-03-18 2004-09-30 The Procter & Gamble Company Composition comprising particulate zinc materials having a defined crystallite size
US8778311B2 (en) 2006-03-22 2014-07-15 The Procter & Gamble Company Oral zinc compositions
ITMI20101153A1 (en) * 2010-06-25 2011-12-26 Farmaceutici Dott Ciccarelli S P A USE OF ANTIBACTERIAL COMPOUNDS FOR ORAL CABLE HYGIENE
EP2399576A1 (en) 2010-06-25 2011-12-28 Farmaceutici Dott. Ciccarelli S.p.A. Use of antibacterial compounds for the oral cavity hygiene
WO2013140136A1 (en) * 2012-03-19 2013-09-26 Isis Innovation Ltd Adjuvants
WO2014134731A1 (en) * 2013-03-07 2014-09-12 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof
CN107847522A (en) * 2015-06-12 2018-03-27 杰富意矿物股份有限公司 Skin trauma or pachylosis therapeutic agent
EP3308794A4 (en) * 2015-06-12 2018-06-20 JFE Mineral Company, Ltd. Therapeutic agent for skin wound or rough skin
US10945935B2 (en) 2016-06-27 2021-03-16 The Procter And Gamble Company Shampoo composition containing a gel network
WO2018105739A1 (en) * 2016-12-09 2018-06-14 Jfeミネラル株式会社 Inorganic composition with excellent property of gradually releasing zinc ion, and production method therefor
JPWO2018105739A1 (en) * 2016-12-09 2019-10-24 Jfeミネラル株式会社 INORGANIC COMPOSITION EXCELLENT IN ZINC ION SUSTAINED RELEASE AND METHOD FOR PRODUCING THE SAME
US20200078396A1 (en) * 2016-12-09 2020-03-12 Jfe Mineral Company, Ltd. Inorganic composition with excellent property of gradually releasing zinc ion, and production method therefor
US10987380B2 (en) 2016-12-09 2021-04-27 Jfe Mineral Company, Ltd. Hydrozincite containing zinc carbonate hydroxide hydrate and method of making
WO2019011553A1 (en) * 2017-07-11 2019-01-17 Beiersdorf Ag Use of electrolytes in cosmetic preparations for selectively reducing a microorganism population on human skin
US11628126B2 (en) 2018-06-05 2023-04-18 The Procter & Gamble Company Clear cleansing composition
US11497691B2 (en) 2018-12-14 2022-11-15 The Procter & Gamble Company Shampoo composition comprising sheet-like microcapsules
US11896689B2 (en) 2019-06-28 2024-02-13 The Procter & Gamble Company Method of making a clear personal care comprising microcapsules
US11932448B2 (en) 2020-02-14 2024-03-19 The Procter & Gamble Company Bottle adapted for storing a liquid composition with an aesthetic design suspended therein
US11633072B2 (en) 2021-02-12 2023-04-25 The Procter & Gamble Company Multi-phase shampoo composition with an aesthetic design

Also Published As

Publication number Publication date
AU4877896A (en) 1996-09-11
GB9503240D0 (en) 1995-04-12
MA23812A1 (en) 1996-10-01

Similar Documents

Publication Publication Date Title
WO1996025913A1 (en) Preparation
Enax et al. Synthetic hydroxyapatite as a biomimetic oral care agent.
KR101091413B1 (en) New crystalline pyrithione/zinc oxide composite and physiologic/antibiotic composition containing the same
EP2812010B1 (en) Multicomponent oral care composition
CN100455569C (en) Novel pyrithione complex compound, process for producing the same and use thereof
JP2003226630A (en) Preparation with deodorizing activity comprising zinc salt of ricinoleic acid and at least one functional amino acid
KR20100043211A (en) Diaphragm analysis method and use of products obtained using the method
CA1198738A (en) Oral compositions comprising n.sup.g-acyl derivatives of arginine
CN105764479B (en) Liquid oral detergent
CN108014287A (en) A kind of effervesce bacteria inhibition tablet and preparation method thereof
KR101625626B1 (en) Soap composition comprising baked shell powder
JPH07116008B2 (en) Antibacterial agent
JP2006199659A (en) Deodorizing and antiperspirant agent
JPS6240323B2 (en)
JP2004250374A (en) Composition for oral cavity
KR101122760B1 (en) Toothpsate composites using mineral and manufacturing method thereof
EP4333617A1 (en) Functionalized biomimetic hydroxyapatite
EP0267994B1 (en) The use of a metal complex for the manufacture of a composition for treating dental structures
JPH05155733A (en) Antiseptic agent for cosmetic and antibacterial cosmetic
JP2865380B2 (en) Antibacterial cosmetic
EP3542776B1 (en) Metal-carbon structure hybrid formulation for dental use in the treatment of dental hypersensitivity, demineralisation and cavities
JP2738942B2 (en) Oral composition containing bivalent and trivalent complex iron salt
CA1290252C (en) Method and compositions for treating dental structures
KR20110020971A (en) The method of preparing soap using mineral water and it's soap
CN116196222A (en) Caries preventing additive, caries preventing material, dental diaphragm and invisible appliance

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN AZ BY KG KZ RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase